HER2 Multiplex Mutation Screening Kit

HER2 gene mutation is closely related to the degree of deterioration of many malignant tumors. Tumors with high HER2 expression show strong metastasis and invasion capabilities, are less sensitive to chemotherapy, and are prone to recurrence.

In a variety of malignant tumors including breast cancer, gastric cancer, lung cancer, etc., HER2 gene mutations indicate poor prognosis and short survival. 

Cancer is a genetic disease with uncontrolled growth of abnormal cells. Some types of cancer are frequently associated with specific genetic mutations. Those mutations provide the biomarkers that allow more specific cancer treatments, known as targeted therapy.

Targeted therapy is a newer type of cancer treatment that offers patients the opportunity to use a drug that has a greater effect on cancerous tissue, reducing many of the side effects associated with standard therapy. Therefore, it is a critical step towards targeted therapy by identifying the cancer mutations with a precise and sensitive method.